# Jasper Therapeutics, Inc.: Form 8-K, filed Jan 4, 2024

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2024-01-04
- Accepted by EDGAR: Jan 4, 2024, 06:04 ET
- Period: 2024-01-03
- Accession: 0001213900-24-000980
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/ea191024-8k_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/ea191024-8k_jasper.htm

Filed Jan 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-000980. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
